1. Allergan $AGN Shareholder Sues Ackman For Insider Trading http://www.bidnessetc.com/31200-allergan-agn-shareholder-sues-ackman-for-insider-trading/ $ACT $VRX

  2. Ackman, Valeant Target Of Lawsuit; Will Allergan’s Pyott Join Plaintiffs? http://www.valuewalk.com/2014/12/ackman-valeant-lawsuit/ $AGN $ACT $VRX

  3. #InsiderTrading Notable Buys And Sales: $ENH $FCX $MAS $RES $TWI $VRX $IPGP $PSEC $SGEN $EVEP $HSIC $NWS $TWTR http://www.talkmarkets.com/content/us-markets/insider-trading-report-edition-234-notable-buys-and-sales?post=54700

  4. Ackman $AGN $VRX insider trading suit - court doc https://www.scribd.com/doc/250519518/Ackman-Suit

  5. Algorithmic trading CLOSING Dec/18 $VRX(0.5 %) $MDT(4.0 %) $TYC(1.0 %) $FBR(-2.1 %) $RRD(-3.8 %) $PBCT(0.7 %) $ZION(-2.5 %) $MWE(-9.6 %)

  6. ...As 9/30/14 here are some of the names . $fb $vrx $lbtyk $flt $chtr $baba http://stocktwits.com/message/30418778

  7. Valeant Pharmaceuticals ($VRX) Named Top Pick for 2015 at BMO Capital http://www.streetinsider.com/Analyst+Comments/Valeant+Pharmaceuticals+%28VRX%29+Named+Top+Pick+for+2015+at+BMO+Capital/10108752.html?si_client=st

  8. Algorithmic trading CLOSING Dec/17 $ETE(-14.2 %) $KMI(-1.4 %) $VRX(-1.6 %) $TIME(0.7 %) $NPSP(11.1 %) $DRH(2.3 %)

  9. Algorithmic trading CLOSING Dec/17 $ETE(-14.2 %) $XIV(-6.7 %) $WMT(0.4 %) $KMI(-1.4 %) $PNR(-5.8 %) $F(-6.8 %) $Z(-7.1 %) $VRX(-1.6 %)

  10. Insider Transaction: $VRX Purchase at $160.48 per share of 500 shares by Director Farmer Ronald Harold on 2014-12-12.

  11. Valeant Pharmaceuticals International director just picked up 500 shares http://www.conferencecalltranscripts.org/summary2/?id=1332670 $VRX

  12. $VRX made a hammer and a stochastic buy signal right at the lower Bollinger Band http://swingtradebot.com/equities/vrx

  13. 4 High-Gross Margin Stocks: $VRX $GOV $BSX $IACI

  14. Insider Trading Report Edition Notable Buys And Sales $RES $VRX $TWI $SGEN $FCX $EVEP $ENH $PSEC $TWTR $MAS http://www.talkmarkets.com/content/us-markets/insider-trading-report-edition-234-notable-buys-and-sales?post=54700

  15. Insider Transaction: $VRX Purchase at $139.29 per share of 50000 shares by Director Ubben Jeffrey W on 2014-12-10.

  16. One of the bigger recent insider buys was yesterday s $35,014,500 purchase of $VRX, according to this list http://www.conferencecalltranscripts.org/insider/

  17. Valeant Pharmaceuticals Intl Insider Jeffrey Ubben Buys $35,015,000 in $VRX http://www.analystratings.net/stocks/NYSE/VRX/?RegistrationCode=SocialMedia-direct&DefaultTab=Insider

  18. Valeant Pharmaceuticals International director just picked up 250,000 shares http://www.conferencecalltranscripts.org/summary/?id=1325617 $VRX

  19. Activist Score Board Tracks Success and Utter Failure http://www.valuewalk.com/2014/12/activist-score-board-tracks-success-utter-failure/ $YHOO $EBAY $HTZ $HLF $AGN $VRX

  20. Index-Crushing Fund Buys Fastenal During Sell-Off http://ycharts.com/analysis/story/indexcrushing_fund_buys_fastenal_during_selloff $FAST $BRK.B $BRK.A $VRX $TJX

  21. From Focus On Acquisitions To Credit Health: Is Valeant Pharmaceuticals Being Wise? http://www.bidnessetc.com/30577-from-focus-on-acquisitions-to-credit-health-is-valeant-pharmaceuticals-vrx/?utm_content=buffer32afa&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer $VRX

  22. Valeant has decided to move away from its growth-by-acquisition strategy - http://www.bidnessetc.com/30577-from-focus-on-acquisitions-to-credit-health-is-valeant-pharmaceuticals-vrx/?utm_content=buffer2fcdc&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer $VRX

  23. Where Could ValueAct Capital s New $1.5 Billion Go? http://www.benzinga.com/trading-ideas/long-ideas/14/12/5067997/where-could-valueact-capitals-new-1-5-billion-go $AGN $AGU $MSFT $VRX

  24. Valeant Pharmaceuticals Downplays Strategy Shift News http://www.valuewalk.com/2014/12/valeant-pharmaceuticals-strategy-shift/ $VRX $AGN $ACT

  25. Why Slashing Debt Is Important For Valeant Pharmaceuticals Intl Inc? $VRX http://investcorrectly.com/20141209/slashing-debt-important-valeant-pharmaceuticals-intl-inc-vrx/